Fatal hepatitis C associated fibrosing cholestatic hepatitis as a complication of cyclophosphamide and corticosteroid treatment of active glomerulonephritis
Journal Title: Annals of Hepatology - Year 2007, Vol 6, Issue 3
Abstract
Fibrosing cholestatic hepatitis (FCH) is an aggressive and usually fatal form of viral hepatitis in immunocompromised patients. It is characterized by progressive cholestasis leading to hepatic failure, and a characteristic histopathological features including: periportal fibrosis, ballooning degeneration of hepatocytes, cholestasis, with minimal inflammation. FCH has been reported almost exclusively in heavily immunosuppressed organ transplant recipients or patients with AIDS. This case report describes a previously immunocompetent patient with previously stable chronic hepatitis C who developed fibrosing cholestatic hepatitis after receiving cyclophosphamide and corticosteroids for active glomerulonephritis.
Authors and Affiliations
Faisal Saleh, Hin Ko, Jennifer Davis, Wichian Apiratpracha, James Powell, Siegfried Erb, Eric Yoshida
Which is the real genotype distribution of hepatitis C virus infection in Mexico?
Efficacy of maintenance subcutaneous hepatitis B immune globulin (HBIG) post-transplant for prophylaxis against hepatitis B recurrence.
Background. Patients who receive liver transplantation for chronic hepatitis B infection require long-term combination therapy with hepatitis B immunoglobulin (HBIG) and oral antiviral medication to prophylax against gra...
Lysophosphatidic acid and atotaxin in patients with cholestasis and pruritus: Fine biology, anticipated discern
Association between type two diabetes and non-alcoholic fatty liver disease in youth
In the last three decades prevalence of insulin related diseases has been growing worldwide with epidemic obesity, type 2 diabetes mellitus and non alcoholic fatty liver disease. In children such epidemics are particular...
Non alcoholic fatty liver disease